Jeffrey Robert Ajer, EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 3,000 shares at $86.12 ($258K) on 2022-11-02, disclosed to the SEC on 2022-11-04.
Seasonal sale ($258k) by EVP, Chief Commercial Officer — this insider has traded BMRN in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2023-09-20 | $3K | — | Filing → |
| BMRN | SELL | 2023-08-17 | $450K | — | Filing → |
| BMRN | SELL | 2023-01-27 | $11.3M | — | Filing → |